InsuletPODD

NASDAQ · USA · Segment 1 of 8 in the Medicine, pharma & life science value chain: Diabetes & metabolic disease

Maker of Omnipod, a tubeless insulin pump that handles dosing automatically.

Diabetes & metabolic disease: Treatment and monitoring of diabetes and metabolic disease, from insulin to glucose monitoring.

Key metrics

Market cap

$10.2B

Price

$145.42

Today

−1.8%

Return YTD

−47.9%

Return 1Y

−54.8%

P/E

27.1

P/S

3.3

P/B

6.7

Data as of 2026-08-25 · updates daily after U.S. close

Theme exposure

DiabetesInsulin pumpsMedtech exposureInsulin deliveryDigital health

In the value chain

Products & services

Omnipod insulin pump
Automated insulin dosing

Competitors

Medtronic Diabetes
Tandem
DexCom (CGM)

Risks

Competition
Reimbursement changes

Supply chain

Supplies →

CVS HealthCVS

Full supply chain for PODD →

Same segment: Diabetes & metabolic disease

Eli LillyLLY DexComDXCM

Compare PODD

PODD vs LLY PODD vs DXCM

See where Insulet sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →